Prediction of Chronic Kidney Disease Following Pre-eclampsia: Diagnosis and Early Care
Recruiting · NCT05056701 · Interventional (participants receive a specific treatment) · Lead sponsor: Centre Hospitalier le Mans
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Pre-eclampsia (PE) is a pregnancy-associated syndrome of variable severity, classically defined by the combination of hypertension and proteinuria in a previously non-hypertensive or proteinuric patient. These symptoms normally resolve within 2-3 months after delivery regardless of the severity of the pre-eclampsia. Regardless of its definition, preeclampsia is associated with an increased risk of obstetric events and, for the mother, an increased risk of developing chronic kidney disease (CKD), hypertension, diabetes and cardiovascular disease in the broad sense. The relationship between preeclampsia and Chronic Kidney Disease is, however, complex and not fully understood. Investigator proposes an interventional study to identify the diagnosis of Chronic Kidney Disease in patients who have developed an episode of Preeclampsia.
Who can take part
Inclusion criteria
- Meeting the preeclampsia criteria or one of its complications (eclampsia, HELLP syndrome) according to the ISSHP 2018 definitions within the last 5 years
- Having signed the informed consent
- Person affiliated to social security
Exclusion criteria
- Patient with mental disability or language barrier preventing understanding of the study or consent
- Person deprived of liberty by judicial or administrative decision
- Person under forced psychiatric care
- Person subject to a legal protection measure
Where it is running
2 locations listed.
- Chu Angers - Angers, France
- Centre Hospitalier Du Mans - Le Mans, France